CMS, FDA Expand Open Data Initiatives
Researchers and analysts looking for patterns in healthcare data are getting access to a second year’s worth of Medicare hospital utilization data as well as a new OpenFDA API for …
mHealth device developers should get acquainted with FDA requirements
As DreamIt Ventures kicks off a call for applications for its second class of DreamIt Health in Philly, more and more applicants have smartphone diagnostic tools. This trend in mhealth …
FDA Approves Highly Anticipated COPD Medication
The Food and Drug Administration has officially approved Breo Ellipta, a much-anticipated new treatment for chronic obstructive pulmonary disease. The inhaled drug was developed by GlaxoSmithKline and Theravance, and is …
FDA Clears ResMed VPAP for COPD Treatment
The FDA grants 510(k) clearance to ResMed’s at-home respiratory device for patients with chronic obstructive pulmonary disease. ResMed out of San Diego, California won FDA clearance and is releasing its …
US FDA Approves ResMed Noninvasive Ventilation Device for COPD Treatment
One in five patients with stage 3 or 4 chronic obstructive pulmonary disease (COPD) hospitalized for acute exacerbations are readmitted to the hospital within 30 days, but these readmissions may …